Sign up to save your podcasts
Or
Share Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 1
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Exploring GLP-1 Receptor Agonists for Neurodegeneration - Part 1
In part one of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss recent clinical trials on exenatide as a disease-modifying therapy for Parkinson disease.
Show reference:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract
View all episodes
By American Academy of Neurology
4.8
129129 ratings
In part one of this two-part series, Dr. Vikram Karnik and Dr. Lorraine Kalia discuss recent clinical trials on exenatide as a disease-modifying therapy for Parkinson disease.
Show reference:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00161-8/abstract
More shows like Neurology Minute
View all
JAMA Editors' Summary
131 Listeners
Neurology® Podcast
288 Listeners
NEJM This Week
324 Listeners
Practical Neurology Podcast
46 Listeners
JAMA Clinical Reviews
493 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
87 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
186 Listeners
Navigating Neuropsychology
343 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
366 Listeners
Continuum Audio
77 Listeners